Matthew G. Wallis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Matthew G. Wallis has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Graham Ball
Anglia Ruskin University
4 shared publications - Karen Clements
NHS England, Birmingham, UK
4 shared publications - Olive Kearins
National Lead Breast Screening QA, Public Health England, Birmingham, UK
4 shared publications - Alastair Mark Thompson
Department of Surgery, Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA
3 shared publications - Andrew Evans
Imaging and Technology, Dundee University, Dundee, United Kingdom of Great Britain and Northern Ireland
3 shared publications - Anthony J. Maxwell
NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, England
3 shared publications
Latest Publications
- Open Access
- 1 June 2020
- Published by Elsevier in The Breast
- Vol. 51, 114-119
Radiological audit of interval breast cancers: Estimation of tumour growth rates
- 1 June 2020
- Published by Elsevier in The Breast
- Vol. 51, 114-119
Open AccessRadiological audit of interval breast cancers: Estimation of tumour growth rates
- Open Access
- 5 February 2020
- Published by Springer Nature in Insights into Imaging
- Vol. 11 (1) , 1-18
Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging
We summarise here the information to be provided to women and referring physicians about percutaneous breast biopsy and lesion localisation under imaging guidance. After explaining why a preoperative diagnosis with a percutaneous biopsy is preferred to surgical biopsy, we illustrate the criteria used by radiologists for choosing the most appropriate combination of device type for sampling and imaging technique for guidance. Then, we describe the commonly used devices, from fine-needle sampling to tissue biopsy with larger needles, namely core needle biopsy and vacuum-assisted biopsy, and how mammography, digital breast tomosynthesis, ultrasound, or magnetic resonance imaging work for targeting the lesion for sampling or localisation. The differences among the techniques available for localisation (carbon marking, metallic wire, radiotracer injection, radioactive seed, and magnetic seed localisation) are illustrated. Type and rate of possible complications are described and the issue of concomitant antiplatelet or anticoagulant therapy is also addressed. The importance of pathological-radiological correlation is highlighted: when evaluating the results of any needle sampling, the radiologist must check the concordance between the cytology/pathology report of the sample and the radiological appearance of the biopsied lesion. We recommend that special attention is paid to a proper and tactful approach when communicating to the woman the need for tissue sampling as well as the possibility of cancer diagnosis, repeat tissue sampling, and or even surgery when tissue sampling shows a lesion with uncertain malignant potential (also referred to as “high-risk” or B3 lesions). Finally, seven frequently asked questions are answered.
- 5 February 2020
- Published by Springer Nature in Insights into Imaging
- Vol. 11 (1) , 1-18
Open AccessImage-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging
We summarise here the information to be provided to women and referring physicians about percutaneous breast biopsy and lesion localisation under imaging guidance. After explaining why a preoperative diagnosis with a percutaneous biopsy is preferred to surgical biopsy, we illustrate the criteria used by radiologists for choosing the most appropriate combination of device type for sampling and imaging technique for guidance. Then, we describe the commonly used devices, from fine-needle sampling to tissue biopsy with larger needles, namely core needle biopsy and vacuum-assisted biopsy, and how mammography, digital breast tomosynthesis, ultrasound, or magnetic resonance imaging work for targeting the lesion for sampling or localisation. The differences among the techniques available for localisation (carbon marking, metallic wire, radiotracer injection, radioactive seed, and magnetic seed localisation) are illustrated. Type and rate of possible complications are described and the issue of concomitant antiplatelet or anticoagulant therapy is also addressed. The importance of pathological-radiological correlation is highlighted: when evaluating the results of any needle sampling, the radiologist must check the concordance between the cytology/pathology report of the sample and the radiological appearance of the biopsied lesion. We recommend that special attention is paid to a proper and tactful approach when communicating to the woman the need for tissue sampling as well as the possibility of cancer diagnosis, repeat tissue sampling, and or even surgery when tissue sampling shows a lesion with uncertain malignant potential (also referred to as “high-risk” or B3 lesions). Finally, seven frequently asked questions are answered.
- Open Access
- 1 September 2018
- Published by Elsevier in European Journal of Cancer
- Vol. 101, 210-219
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project
- 1 September 2018
- Published by Elsevier in European Journal of Cancer
- Vol. 101, 210-219
Open AccessManagement and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project
- Open Access
- 1 May 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (5) , 467-472
Does preoperative axillary staging lead to overtreatment of women with screen-detected breast cancer?
- 1 May 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (5) , 467-472
Open AccessDoes preoperative axillary staging lead to overtreatment of women with screen-detected breast cancer?
- Open Access
- 1 April 2018
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 44 (4) , 429-435
Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ
- 1 April 2018
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 44 (4) , 429-435
Open AccessRisk factors for the development of invasive cancer in unresected ductal carcinoma in situ
- Open Access
- 1 April 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (4) , 372-380
How do we manage overdiagnosis/overtreatment in breast screening?
- 1 April 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (4) , 372-380
Open AccessHow do we manage overdiagnosis/overtreatment in breast screening?
- Open Access
- 1 November 2017
- Published by Elsevier in Radiography
- Vol. 23 (4) , 343-349
Mammographic image quality in relation to positioning of the breast: A multicentre international evaluation of the assessment systems currently used, to provide an evidence base for establishing a standardised method of assessment
- 1 November 2017
- Published by Elsevier in Radiography
- Vol. 23 (4) , 343-349
Open AccessMammographic image quality in relation to positioning of the breast: A multicentre international evaluation of the assessment systems currently used, to provide an evidence base for establishing a standardised method of assessment
- 1 July 2014
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (11) , 1880-1890
Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast
- 1 July 2014
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (11) , 1880-1890
Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast
- Open Access
- 10 January 2014
- Published by Springer Nature in Trials
- Vol. 15 (1) , 17
Changing case Order to Optimise patterns of Performance in mammography Screening (CO-OPS): study protocol for a randomized controlled trial
X-ray mammography remains the predominant test for screening for breast cancer, with the aim of reducing breast cancer mortality. In the English NHS Breast Screening Programme each woman’s mammograms are examined separately by two expert readers. The two readers read each batch in the same order and each indicates if there should be recall for further tests. This is a highly skilled, pressurised, repetitive and frequently intellectually unchallenging activity where readers examine one or more batches of 30–50 women’s mammograms in each session. A vigilance decrement or performance decrease over time has been observed in similar repetitive visual tasks such as radar operation.
- 10 January 2014
- Published by Springer Nature in Trials
- Vol. 15 (1) , 17
Open AccessChanging case Order to Optimise patterns of Performance in mammography Screening (CO-OPS): study protocol for a randomized controlled trial
X-ray mammography remains the predominant test for screening for breast cancer, with the aim of reducing breast cancer mortality. In the English NHS Breast Screening Programme each woman’s mammograms are examined separately by two expert readers. The two readers read each batch in the same order and each indicates if there should be recall for further tests. This is a highly skilled, pressurised, repetitive and frequently intellectually unchallenging activity where readers examine one or more batches of 30–50 women’s mammograms in each session. A vigilance decrement or performance decrease over time has been observed in similar repetitive visual tasks such as radar operation.
- Open Access
- 19 April 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 106 (10) , 1611-1617
The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS
Background: Methods: Results: Interpretation:
- 19 April 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 106 (10) , 1611-1617
Open AccessThe effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS
Background: Methods: Results: Interpretation: